No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	SP2577 Sensitive: B - Late Trials SP2577 Sensitive : B	SP2577 Sensitive: B - Late Trials SP2577 Sensitive : B
TAF15-CHN1 translocation	Osteosarcoma	TAF15-CHN1 translocation	Osteosarcoma	SP2577 Sensitive: C3 – Early Trials SP2577 Sensitive : C3	SP2577 Sensitive: C3 – Early Trials SP2577 Sensitive : C3
FUS-DDIT3 translocation	Liposarcoma	FUS-DDIT3 translocation	Liposarcoma	SP2577 Sensitive: C3 – Early Trials SP2577 Sensitive : C3	SP2577 Sensitive: C3 – Early Trials SP2577 Sensitive : C3
SMARCA4 mutation	Ovarian Cancer	SMARCA4 mutation	Ovarian Cancer	SP2577 Sensitive: C4 – Case Studies SP2577 Sensitive : C4	SP2577 Sensitive: C4 – Case Studies SP2577 Sensitive : C4
KDM1A overexpression	Osteosarcoma	KDM1A overexpression	Osteosarcoma	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D
KDM1A overexpression	Rhabdomyosarcoma	KDM1A overexpression	Rhabdomyosarcoma	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D
KDM1A overexpression	Ewing Sarcoma	KDM1A overexpression	Ewing Sarcoma	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D	SP2577 Sensitive: D – Preclinical SP2577 Sensitive : D

seclidemstat (SP2577)

Associations
(7)